RSS Feed
Search Ask-Cato.com
Tags
adverse events biologics biosimilar biotech cancer Cato BioVentures Cato Research CDER clinical investigator clinical research clinical trials CMC conference CROs DIA drug development eCTD efficacy FDA funding GlobalSubmit guidance Health Canada IND in vitro diagnostics labeling manufacturing marketing application medical devices NDA NIH nonclinical research oncology Phase 1 Phase 2 postmarketing protocol regulatory affairs safety statistical analysis toxicology transparency venture capital warning letters webinarCategories
- Clinical Trials (52)
- Conferences and Meetings (34)
- eCTD (26)
- FDA (71)
- Guest Posts (5)
- Health Canada (6)
- Industry News (56)
- Project Management (1)
- Publications (7)
- Regulatory Strategy (36)
- Social Media (6)
- Statistics (9)
- Uncategorized (1)
- Venture Capital (10)
- Webinars (24)
Tag Archives: healthcare reform
Recap of the 20th CED Biotech/Life Sciences Conference
The 20th Annual Council for Entrepreneurial Development (CED) Biotech/Life Science Conference was held on 21-22 February 2011 in Raleigh, North Carolina. Continue reading
Posted in Conferences and Meetings, Industry News, Venture Capital
Tagged biotech, capi, Cato BioVentures, Cato Research, clinical research, conference, development plan, drug development, funding, healthcare reform, Phase 2, Phase 3, venture capital
Comments Off
How will Healthcare Reform Impact Your Next Investigator Meeting?
The new Healthcare reform legislation can be debated by Americans for days on end, but tucked in among all of the changes for Medicare beneficiaries, pre-existing conditions, and the effects on small business owners lays a provision that most layman would not even notice. This provision, however, has the attention of US drug and device manufacturers and cannot be ignored. Continue reading
Posted in Clinical Trials, Conferences and Meetings, FDA, Industry News, Webinars
Tagged clinical trials, guest post, healthcare reform, HHS, investigator meetings, webinar
Comments Off
Drug/Biologic/Device Highlights from the Health Care Reform Bill
Cautious, careful people, always casting about to preserve their reputations… can never effect a reform. – Susan B. Anthony Last month, the company behind the FDA Law Blog, Hyman, Phelps & McNamara, P.C., prepared a memo that outlines the provisions … Continue reading
Biotech Wins Protection From Biosimilars
Love is the power to see similarity in the dissimilar. – Theodor Adorno When President Obama signed the healthcare reform legislation into law, he also handed a major victory to biotech companies. Unless you’ve been stranded on a deserted island … Continue reading
Posted in Industry News
Tagged biologics, biosimilar, follow-on biologics, healthcare reform, legislation, medical devices, obama, taxes
1 Comment
